Fu Wei
SEC insider (Form 3/4/5 filer). CIK 0001885756. Director at NovaBridge Biosciences (NBP). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 29, 2026. Located in ROCKVILLE, MD.
Companies Fu Wei has filed insider reports for
- NovaBridge Biosciences (NBP): Director
Fu Wei
CIK: 0001885756
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NovaBridge Biosciences
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 29, 2026NBP
NovaBridge Biosciences
AwardDirect2025 Employee Share Option (right to buy)
725.1K shares- - Jun 29, 2026NBP
NovaBridge Biosciences
AwardDirect2025 Employee Share Option (right to buy)
1.1M shares- - Jun 29, 2026NBP
NovaBridge Biosciences
AwardDirect2025 Employee Share Option (right to buy)
1.1M shares- - Jun 29, 2026NBP
NovaBridge Biosciences
AwardDirectRestricted Share Units
1M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 29, 2026 | NBP NovaBridge Biosciences | Award 2025 Employee Share Option (right to buy) | 725,140 | - | - | Direct |
| Jun 29, 2026 | NBP NovaBridge Biosciences | Award 2025 Employee Share Option (right to buy) | 1,087,720 | - | - | Direct |
| Jun 29, 2026 | NBP NovaBridge Biosciences | Award 2025 Employee Share Option (right to buy) | 1,087,720 | - | - | Direct |
| Jun 29, 2026 | NBP NovaBridge Biosciences | Award Restricted Share Units | 1,010,100 | - | - | Direct |
1-4 of 4 transactions